Literature DB >> 8645584

Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.

R B Veenhuizen1, J P Marijnissen, P Kenemans, M C Ruevekamp-Helmers, L W 't Mannetje, T J Helmerhorst, F A Stewart.   

Abstract

The goal of this study was to investigate the efficacy of photodynamic therapy (PDT) of a single tumour growing intraperitoneally. For this purpose the CC531 colon carcinoma, implanted in an intraperitoneal fat pad of Wag/RijA rats, was treated with intraperitoneal photodynamic therapy (IPPDT) using Photofrin as the photosensitiser. Two illumination techniques have been compared. An invasive illumination technique using Perspex blocks to illuminate 30 cm2 of the lower abdomen gave a significant delay in tumour growth with 25 J cm-2 applied 1 day after Photofrin. A minimally invasive illumination technique using a balloon catheter to illuminate 14 cm2 resulted in an equivalent growth delay with 75 J cm-2. The route of administration of the photosensitiser did not influence regrowth times of the tumour. Mitomycin C (MMC), a bioreductive agent, was used to exploit the known PDT-induced hypoxia. The combination of IPPDT with MMC resulted in an increased tumoricidal effect. In conclusion, IPPDT led to a significant growth delay for a single tumour implanted intraperitoneally and repetition of the PDT treatment was possible using a minimally invasive illumination technique. Repeated treatments resulted in increased tumour response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645584      PMCID: PMC2074484          DOI: 10.1038/bjc.1996.263

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

Review 1.  Mitomycin C: mechanism of action, usefulness and limitations.

Authors:  J Verweij; H M Pinedo
Journal:  Anticancer Drugs       Date:  1990-10       Impact factor: 2.248

2.  Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors.

Authors:  T F DeLaney; W F Sindelar; Z Tochner; P D Smith; W S Friauf; G Thomas; L Dachowski; J W Cole; S M Steinberg; E Glatstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-02-15       Impact factor: 7.038

3.  Treatment of murine intraperitoneal ovarian ascitic tumor with hematoporphyrin derivative and laser light.

Authors:  Z Tochner; J B Mitchell; F S Harrington; P Smith; D T Russo; A Russo
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

4.  Changes in perfusion of mouse tumours after photodynamic therapy.

Authors:  I P van Geel; H Oppelaar; Y G Oussoren; F A Stewart
Journal:  Int J Cancer       Date:  1994-01-15       Impact factor: 7.396

5.  Intraperitoneal photodynamic therapy in the rat: comparison of toxicity profiles for photofrin and MTHPC.

Authors:  R B Veenhuizen; M C Ruevekamp-Helmers; T J Helmerhorst; P Kenemans; W J Mooi; J P Marijnissen; F A Stewart
Journal:  Int J Cancer       Date:  1994-12-15       Impact factor: 7.396

6.  Intravenous vs intraperitoneal sensitizer: implications for intraperitoneal photodynamic therapy.

Authors:  R R Perry; P D Smith; S Evans; H I Pass
Journal:  Photochem Photobiol       Date:  1991-03       Impact factor: 3.421

7.  Enhancement of interstitial photodynamic therapy by mitomycin C and EO9 in a mouse tumour model.

Authors:  P Baas; C Michielsen; H Oppelaar; N van Zandwijk; F A Stewart
Journal:  Int J Cancer       Date:  1994-03-15       Impact factor: 7.396

8.  Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer.

Authors:  J P Neijt; W W ten Bokkel Huinink; M E van der Burg; A T van Oosterom; P H Willemse; J B Vermorken; A C van Lindert; A P Heintz; E Aartsen; M van Lent
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

9.  Photodynamic therapy of ascites tumours within the peritoneal cavity.

Authors:  Z Tochner; J B Mitchell; P Smith; F Harrington; E Glatstein; D Russo; A Russo
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640

10.  Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.

Authors:  I P van Geel; H Oppelaar; Y G Oussoren; J J Schuitmaker; F A Stewart
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

View more
  6 in total

1.  Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model.

Authors:  Wieland Raue; Maik Kilian; Chris Braumann; Vladimir Atanassow; Anna Makareinis; Sonja Caldenas; Wolfgang Schwenk; Jens Hartmann
Journal:  Int J Colorectal Dis       Date:  2009-11-10       Impact factor: 2.571

2.  First surgical tumour reduction of peritoneal surface malignancy in a rat's model.

Authors:  Jens Hartmann; Maik Kilian; Vladimir Atanassov; Chris Braumann; Juergen Ordemann; Christoph A Jacobi
Journal:  Clin Exp Metastasis       Date:  2008-02-27       Impact factor: 5.150

3.  A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis.

Authors:  Joerg O W Pelz; Joerg Doerfer; Werner Hohenberger; Thomas Meyer
Journal:  BMC Cancer       Date:  2005-05-30       Impact factor: 4.430

4.  Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates.

Authors:  M Del Governatore; M R Hamblin; E E Piccinini; G Ugolini; T Hasan
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

Review 5.  Investigation of Metastasis-Related Genes: A Rat Model Mimicking Liver Metastasis of Colorectal Carcinoma.

Authors:  Hassan Adwan; Rania Georges; Asim Pervaiz; Martin R Berger
Journal:  Front Oncol       Date:  2017-07-18       Impact factor: 6.244

6.  Enhancing photodynamyc therapy efficacy by combination therapy: dated, current and oncoming strategies.

Authors:  Ilaria Postiglione; Angela Chiaviello; Giuseppe Palumbo
Journal:  Cancers (Basel)       Date:  2011-06-09       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.